Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Anaplastic Oligoastrocytoma Global Clinical Trials Review, H1, 2014
Publication Date Mar 2014
Product Type Report
Pages 80
Single User License help $ 2500.00
Site User License help $ 5000.00
Corporate User License help $ 7500.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Anaplastic Oligoastrocytoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Anaplastic Oligoastrocytoma Global Clinical Trials Review, H1, 2014" provides data on the Anaplastic Oligoastrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Oligoastrocytoma . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Oligoastrocytoma . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Anaplastic Oligoastrocytoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Anaplastic Oligoastrocytoma 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Anaplastic Oligoastrocytoma Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Tocagen Inc. 29
Clinical Trial Overview of Tocagen Inc. 29
Shandong Lanjin Pharmaceuticals Co. Ltd 30
Clinical Trial Overview of Shandong Lanjin Pharmaceuticals Co. Ltd 30
Insys Therapeutics, Inc. 31
Clinical Trial Overview of Insys Therapeutics, Inc. 31
Keryx Biopharmaceuticals, Inc. 32
Clinical Trial Overview of Keryx Biopharmaceuticals, Inc. 32
Biogen Idec Inc. 33
Clinical Trial Overview of Biogen Idec Inc. 33
Clinical Trial Overview of Top Institutes / Government 34
National Cancer Institute 34
Clinical Trial Overview of National Cancer Institute 34
Memorial Sloan Kettering Cancer Center 35
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 35
City of Hope National Medical Center 36
Clinical Trial Overview of City of Hope National Medical Center 36
Barbara Ann Karmanos Cancer Institute 37
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 37
Radiation Therapy Oncology Group 38
Clinical Trial Overview of Radiation Therapy Oncology Group 38
Rush University Medical Center 39
Clinical Trial Overview of Rush University Medical Center 39
University of Washington 40
Clinical Trial Overview of University of Washington 40
Hopitaux Universitaires de Geneve 41
Clinical Trial Overview of Hopitaux Universitaires de Geneve 41
University of California, San Diego 42
Clinical Trial Overview of University of California, San Diego 42
Five Key Clinical Profiles 43
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables
List of Tables
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Anaplastic Oligoastrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Anaplastic Oligoastrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Anaplastic Oligoastrocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Anaplastic Oligoastrocytoma Therapeutics, Global, Suspended Clinical Trials, 2014* 22
Anaplastic Oligoastrocytoma Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Anaplastic Oligoastrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tocagen Inc., 2014* 29
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong Lanjin Pharmaceuticals Co. Ltd, 2014* 30
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Insys Therapeutics, Inc., 2014* 31
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Keryx Biopharmaceuticals, Inc., 2014* 32
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 33
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 34
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 35
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 36
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014* 37
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014* 38
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2014* 39
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 40
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2014* 41
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 42

List of Figures
List of Figures
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Anaplastic Oligoastrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Anaplastic Oligoastrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Anaplastic Oligoastrocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Anaplastic Oligoastrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 78

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
China Pharmaceutical Guidebook Series (4) Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
By Access China Management Consulting Ltd
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of tradition ...Read More
May 2015 $750.00
Latest Guide to Chinese Pharmaceutical GMP Regulations
By Access China Management Consulting Ltd
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) ...Read More
Jul 2015 $750.00
"Acne vulgaris "- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acne vulgaris  - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and ...Read More
Apr 2016 $4950.00
"Acute coronary syndrome(ACS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of th ...Read More
Apr 2016 $4950.00
"Acute heart failure(AHF)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the di ...Read More
Apr 2016 $4950.00
"Acute ischemic stroke (AIS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the ...Read More
Apr 2016 $4950.00
"Acute lymphoblastic leukemia (ALL)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute lymphoblastic leukemia (ALL) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview ...Read More
Apr 2016 $4950.00
"Age-related macular degeneration (AMD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overv ...Read More
Apr 2016 $4950.00
"Alzheimer’s disease (AD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the d ...Read More
Apr 2016 $4950.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  GlobalData

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z